Jacques Dessureault
Chairman at Optina Diagnostics, Inc.
Net worth: 2 331 $ as of 2024-03-30
Profile
Jacques Dessureault is currently the Chairman at Optina Diagnostics, Inc. He previously held positions as the President & Director at Valeant Canada Ltd.
from 2012 to 2017, Lead Independent Director at BZAM Ltd.
from 2019 to 2023, President & General Manager at Bausch Health Americas, Inc., Head-Global Marketing Division at Novartis AG, President & General Manager at Bausch Health Cos., Inc., Vice President at Bristol-Myers Squibb Canada Co., and General Manager & Head-Business Unit at Novartis Pharma Canada, Inc. Mr. Dessureault has a graduate degree from the University of Leicester and an undergraduate degree from École Des Sciences De La Gestion.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BZAM LTD
0.03% | 2022-11-24 | 63,003 ( 0.03% ) | 2 331 $ | 2024-03-30 |
Jacques Dessureault active positions
| Companies | Position | Start |
|---|---|---|
Optina Diagnostics, Inc.
 Optina Diagnostics, Inc. Medical SpecialtiesHealth Technology Optina Diagnostics, Inc. manufactures retinal diagnostic imaging devices to detect alzheimer's diseases. The company is headquartered in Montréal, Canada. | Chairman | - |
Former positions of Jacques Dessureault
| Companies | Position | End |
|---|---|---|
| BZAM LTD. | Director/Board Member | 2023-04-27 |
Valeant Canada Ltd.
 Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | President | 2017-05-31 |
| Novartis Pharma Canada, Inc. | Corporate Officer/Principal | - |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | President | - |
| NOVARTIS AG | Sales & Marketing | - |
Training of Jacques Dessureault
| University of Leicester | Graduate Degree |
| École Des Sciences De La Gestion | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| BAUSCH HEALTH COMPANIES INC. | Health Technology |
| BZAM LTD. | Process Industries |
| Private companies | 5 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Health Technology |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Health Technology |
| Novartis Pharma Canada, Inc. | |
Optina Diagnostics, Inc.
Optina Diagnostics, Inc. Medical SpecialtiesHealth Technology Optina Diagnostics, Inc. manufactures retinal diagnostic imaging devices to detect alzheimer's diseases. The company is headquartered in Montréal, Canada. | Health Technology |
- Stock Market
- Insiders
- Jacques Dessureault
